Enanta Pharmaceuticals Inc
ENTA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001177648
No open-market purchases or sales by Enanta Pharmaceuticals Inc insiders were filed in the last 90 days; 122 institutions reported holding it in 13F filings for Q2 2026, worth $397.2M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Enanta Pharmaceuticals Inc as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 101
- −7 vs. Q1 2024
- Shares held
- 22.1M
- −278.6K (−1.2%) vs. Q1 2024
- Total value
- $287.0M
- −$104.4M (−26.7%) vs. Q1 2024
- New holders
- 11
- 33 more added
- Sold out
- 18
- 44 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ENTA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 122 | $397.2M |
| Q1 2026 | 133 | $338.1M |
| Q4 2025 | 132 | $416.1M |
| Q3 2025 | 122 | $227.1M |
| Q2 2025 | 108 | $139.4M |
| Q1 2025 | 110 | $102.8M |
| Q4 2024 | 108 | $114.5M |
| Q3 2024 | 112 | $220.0M |
| Q2 2024 | 101 | $287.0M |
| Q1 2024 | 108 | $391.4M |
| Q4 2023 | 106 | $188.4M |
| Q3 2023 | 132 | $225.0M |
| Q2 2023 | 134 | $438.4M |
| Q1 2023 | 145 | $805.3M |
| Q4 2022 | 147 | $894.5M |
| Q3 2022 | 160 | $1.02B |
| Q2 2022 | 155 | $956.3M |
| Q1 2022 | 170 | $1.40B |
| Q4 2021 | 181 | $1.40B |
| Q3 2021 | 149 | $1.10B |
| Q2 2021 | 152 | $828.7M |
| Q1 2021 | 150 | $956.7M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Enanta Pharmaceuticals Inc; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Farallon Capital Management, L.L.C. | 2,095,000 | $27.2M | 0.16% | 00.0% | Unchanged |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −44,629−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −18,005−100.0% | Sold out |
| Nebula Research & Development LLC | 0 | $0 | 0.00% | −15,745−100.0% | Sold out |
| State Board of Administration of Florida Retirement System | 0 | $0 | 0.00% | −6,781−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −14,282−100.0% | Sold out |
| Hennion & Walsh Asset Management, Inc. | 0 | $0 | 0.00% | −13,689−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −11,333−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −10,927−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −10,405−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −9,985−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −7,574−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −1,114−100.0% | Sold out |
| Headlands Technologies LLC | 0 | $0 | 0.00% | −1,052−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −400−100.0% | Sold out |
| Comerica Bank | 0 | $0 | 0.00% | −333−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −163−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −86−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −4−100.0% | Sold out |